Lv71
4840 积分 2022-09-28 加入
Multispecific T-cell engagers attract cancer drug developers
2小时前
已完结
Shifts in pharma’s therapeutic area focus
24天前
已完结
Shifts in pharma’s therapeutic area focus
1个月前
已完结
The landscape for therapeutic cancer vaccines
1个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
1个月前
已完结
The therapeutic potential of orphan adhesion G-protein-coupled receptors
1个月前
已完结
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
1个月前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
皖公网安备34019202002308
